icon-folder.gif   Conference Reports for NATAP  
 
  HIV Glasgow
23-26 October 2016
Glasgow, UK
Back grey_arrow_rt.gif
 
 
 
Efficacy of Dolutegravir/Abacavir/Lamivudine Fixed-Dose Combination Compared With Ritonavir-Boosted Atazanavir Plus Tenofovir Disoproxil Fumarate/Emtricitabine in Treatment-Naive Women With HIV-1 Infection (ARIA Study): Subgroup Analyses
 
 
  Reported by Jules Levin
HIV Glasgow 2016 Oct 23-26
 
M Johnson,1 C Gatey,2 W Manosuthi,3 A Lazzarin,4 D Podzamczer,5 CY Man,6 A Aylott,7 AM Buchanan,6 B Wynne,8 C Vavro,6 M Aboud,9 KY Smith6
1Royal Free Hospital, London, UK; 2Hpital Saint Louis, Paris, France; 3Bamrasnaradura Institute, Nonthaburi, Thailand; 4IRCCS Ospedale San Raffaele, Milan, Italy; 5Hospital Universitari de Bellvitge, L'Hospitalet, Barcelona, Spain; 6ViiV Healthcare, Research Triangle Park, NC, USA; 7GlaxoSmithKline, Stockley Park, UK; 8ViiV Healthcare, Collegeville, PA, USA; 9ViiV Healthcare, Brentford, UK

HIV1

HIV2

HIV3

HIV4